REPL
Replimune Group, Inc. · Healthcare
Director Jason P Rhodes sold $2.7M of Replimune Group, Inc.
Sold$2,749,721
$42.28Price
65,029Shares
−77%Stake
What REPL did after the filing
Prices for REPL after this filing aren't in yet.
Traded Tue, Dec 15. Filed Thu, Dec 17, 6:21 PM ET, after the close. Not investment advice.